Ascendis Pharma A/S
ASNDNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $15.48B
- P/E (TTM)
- 18.23
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $186.05$282.15
- Volume (live)
- -
- Avg. volume (3M)
- 857.03K
Ascendis Pharma A/S (ASND) Stock Price & Financial Analysis
Ascendis Pharma A/S Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $223.78 - $226.76 |
|---|---|
| 52-Week High | $282.15 |
| 52-Week Low | $186.05 |
| Open | $226.62 |
| Volume (last close) | 680.31K |
| Average Volume (3M) | 857.03K |
| Revenue (TTM) | 1.18B |
|---|---|
| Net Income (TTM) | 849.15M |
| Free Cash Flow (TTM) | 376.36M |
| EPS (TTM) | $13.34 |
| Profit Margin | 71.88% |
| Operating Margin | 10.09% |
| Return on Equity (ROE) | 52.60% |
| Debt to Equity | 0.31 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 15.48B |
|---|---|
| Shares Outstanding | 68.32M |
| P/E Ratio (TTM) | 18.23 |
| Price to Sales (P/S) | 13.11 |
| Price to Book (P/B) | 9.59 |
| EV/EBITDA | 62.76 |
| 50-Day MA | $244.99 |
|---|---|
| 200-Day MA | $236.35 |
| 1-Year Change | +7.66% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Ascendis Pharma A/S at a Glance
As of the Oct 16, 2026 close, Ascendis Pharma A/S (ASND) has a market capitalization of $15.48B. The stock trades at 18.2× trailing earnings and 13.1× sales. Over the trailing twelve months it earned $849.15M on revenue of $1.18B (a 71.9% profit margin) and generated $376.36M of free cash flow. Revenue grew 112.9% year over year.
As of its latest reported balance sheet, it holds $912.91M in cash and securities against $505.84M of debt, a net cash position of $407.06M.
Ascendis Pharma A/S does not currently pay a dividend.
The share price is up 7.7% over the past year. At $225.24 (the Oct 16, 2026 close) it sits within its 52-week range of $186.05 to $282.15, below its 200-day moving average of $236.35.
Based on 18 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $317.47, 40.9% above the Oct 16, 2026 close.
Frequently Asked Questions About Ascendis Pharma A/S
What is the current stock price for ASND?
As of the Oct 16, 2026 close, ASND stock trades at $225.24. The 52-week range is $186.05–$282.15, with a day range of $223.78–$226.76.
What is the P/E ratio for ASND?
As of the Oct 16, 2026 close, Ascendis Pharma A/S's trailing twelve-month (TTM) P/E ratio is 18.2, meaning investors pay $18.2 for every $1 of annual earnings. Ascendis Pharma A/S operates in the Healthcare sector.
Does ASND pay dividends?
Ascendis Pharma A/S does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ASND?
Based on ratings from 18 professional analysts over the last 90 days, the consensus for ASND is Buy. The average 12-month price target is $317.47, a 40.9% upside from the Oct 16, 2026 close of $225.24.
What is the market cap of ASND?
As of the Oct 16, 2026 close, Ascendis Pharma A/S's market capitalization is $15.39B, classifying it as a large-cap company. Ascendis Pharma A/S operates in the Healthcare sector within the Biotechnology industry.